Zhiguang Guo, MD, PhD, Lab
At the clinical onset of type 1 diabetes (T1D), human patients still have some functional beta cell mass remaining. If we could control autoimmunity against beta cells, T1D may be cured by increasing the remaining β cell mass to restore normoglycemia. The goal of current research in my laboratory is to develop therapeutic approaches to treating T1D by ameliorating autoimmunity and by promoting beta cell survival and regeneration.
Primary Research Group
Secondary Research Groups
Our current research interests are focused on:
Zhiguang Guo, MD, PhD
The Sanford Project, Sanford Research
Department of Pediatrics and Department of Surgery
Sanford School of Medicine
The University of South Dakota
Sanford Research Center
2301 East 60th Street North
Sioux Falls, SD 57104
Access Dr. Guo's publications here.